Preclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeys

PURPOSE: To translate a recombinant peptide containing the amino-terminal fragment (ATF) of urokinase plasminogen activator receptor-targeted magnetic iron oxide (IO) nanoparticles (uPAR-targeted human ATF-IONPs) into clinical applications, we conducted a pilot study to evaluate the toxicity and pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yushu, Gong, Li, Gao, Ning, Liao, Jichun, Sun, Jiayu, Wang, Yuqing, Wang, Lei, Zhu, Pengjin, Fan, Qing, Wang, Yongqiang Andrew, Zeng, Wen, Mao, Hui, Yang, Lily, Gao, Fabao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630189/
https://www.ncbi.nlm.nih.gov/pubmed/26604745
http://dx.doi.org/10.2147/IJN.S90587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630189/
https://www.ncbi.nlm.nih.gov/pubmed/26604745
http://dx.doi.org/10.2147/IJN.S90587

Ejemplares similares